Estimates the probability of rheumatoid arthritis–associated pulmonary fibrosis using a 5-variant genetic risk score plus clinical variables from the externally validated modified VARA-ILD-CRS.
INSTRUCTIONS
Use in adults with rheumatoid arthritis (RA) when genetic data for the included variants are available, and the goal is to estimate the risk of RA-associated pulmonary fibrosis/interstitial lung disease to help inform screening intensity or further pulmonary evaluation.
Age*Use the patient’s current age.
years
Male sex*
Ever smoker*
Mean DAS28-CRP*Enter the mean DAS28-CRP value when available.